Biological markers: Tailoring treatment and trials to prognosis

Biological markers: Tailoring treatment and trials to prognosis

Show other versions (1)

Detalhes bibliográficos
Main Authors:	Kerr, D, Shi, Y
Formato:	Journal article
Idioma:	English
Publicado em:	2013

Registos relacionados

Biological markers: Tailoring treatment and trials to prognosis
Por: Kerr, D, et al.
Publicado em: (2013)

The Correlation Between Biological Markers and Prognosis in Thyroid Cancer
Por: Rami Hajjar, et al.
Publicado em: (2024-12-01)

Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease
Por: Edouard Louis
Publicado em: (2020-01-01)

Biological markers of favourable prognosis and successful pleurodesis for malignant pleural effusion
Por: Psallidas, I, et al.
Publicado em: (2016)

Tailored Biologics Selection in Severe Asthma
Por: Sang Hyuk Kim, et al.
Publicado em: (2024-01-01)

Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent
Por: Domingo, E, et al.
Publicado em: (2018)

Markers of oncological prognosis in the surgical treatment of oral squamous cell carcinoma
Por: A. I. Stukan, et al.
Publicado em: (2024-04-01)

Moving Toward Patient-Tailored Treatment in ALS and FTD: The Potential of Genomic Assessment as a Tool for Biological Discovery and Trial Recruitment
Por: Iris J. Broce, et al.
Publicado em: (2021-03-01)

NOVEL OPTICAL PROTEOMICS MOLECULARLY PROFILES BREAST CANCER PATIENTS LEADING TO INDIVIDUALISED PROGNOSIS AND TAILORED TREATMENT
Por: Kelleher, M, et al.
Publicado em: (2009)

MARKERS AND PROGNOSIS IN MULTIPLE-SCLEROSIS
Por: Noseworthy, J, et al.
Publicado em: (1983)

Tailor treatment to the patient in stable angina.
Por: Taggart, D
Publicado em: (2011)

Tailored carbon-based nanomaterials for biological energy electrocatalysis
Por: Quinson, J
Publicado em: (2015)

Tailored Functionalization of Natural Phenols to Improve Biological Activity
Por: Barbara Floris, et al.
Publicado em: (2021-09-01)

An evaluation of tailored psychological treatment of insomnia.
Por: Espie, C, et al.
Publicado em: (1989)

“Read” and ‘Tailor’ Your Treatment
Por: Kausalya Sahu, et al.
Publicado em: (2019-11-01)

Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments
Por: Xueting Hu, et al.
Publicado em: (2022-07-01)

N7-methylguanosine methylation-related regulator genes as biological markers in predicting prognosis for melanoma
Por: Jiehua Deng, et al.
Publicado em: (2022-12-01)

Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial.
Por: Lennox, A, et al.
Publicado em: (2001)

Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial
Por: Lennox, A, et al.
Publicado em: (2001)

CAPS markers in plant biology
Por: Y. N. Shavrukov
Publicado em: (2015-07-01)

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
Por: Domingo, E, et al.
Publicado em: (2018)

Toward neuromarkers for tailored smoking cessation treatments
Por: Francesco Versace, et al.
Publicado em: (2023-06-01)

Tailoring surfaces : modifying surface composition and structure for applications in tribology, biology and catalysis /
Por: 511742 Spencer, Nicholas D.
Publicado em: (c201)

Single-cell analyses to tailor treatments
Por: Benson, Mikael, et al.
Publicado em: (2018)

Correction: Improving Nutrition and Activity Behaviors Using Digital Technology and Tailored Feedback: Protocol for the Tailored Diet and Activity (ToDAy) Randomized Controlled Trial
Por: Halse, Rhiannon E, et al.
Publicado em: (2020-12-01)

Computational design of anti-cancer peptides tailored to target specific tumor markers
Por: Aisha Naeem, et al.
Publicado em: (2024-02-01)

Cuproptosis-related lncRNAs and genes: Potential markers for glioblastoma prognosis and treatment.
Por: Yajia Chen, et al.
Publicado em: (2025-01-01)

Markers of early disease and prognosis in COPD
Por: Morten Dahl, et al.
Publicado em: (2009-04-01)

New Biological Markers of Bone Metabolism in Osteoporosis Treatment
Por: Sun Wook Cho
Publicado em: (2016-09-01)

The modified coughlin osteotomy for surgical treatment of high-grade tailor’s bunion
Por: Shi-Ming Feng MD
Publicado em: (2018-09-01)

What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
Por: Johnstone, E, et al.
Publicado em: (2008)

Tailoring Biologic Therapies for Pediatric Severe Asthma: A Comprehensive Approach
Por: Claudia María Chaverri Repáraz, et al.
Publicado em: (2025-01-01)

Tailoring two-dimensional nanomaterials by structural engineering for chemical and biological sensing
Por: Bo Zhang, et al.
Publicado em: (2020-11-01)

Tailored nanocrystal catalysts
Por: Zhao, Y
Publicado em: (2023)

Tailored Base Surge Policy for Middle Echelon in Biologics Supply Chain
Por: Pedroni, David
Publicado em: (2022)

PB1811: BIOLOGIC AND CLINICAL SIGNIFICANCE OF CD7 ABERRANT EXPRESSION IN ACUTE MYELOID LEUKEMIA: A POOR PROGNOSIS MARKER
Por: H. Charfi, et al.
Publicado em: (2022-06-01)

Characterization of a Clinically and Biologically Defined Subgroup of Patients with Autism Spectrum Disorder and Identification of a Tailored Combination Treatment
Por: Laura Pérez-Cano, et al.
Publicado em: (2024-04-01)

Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma
Por: Caroline Y. K. Fong, et al.
Publicado em: (2019-01-01)

Pleomorphic Liposarcoma Unraveled: Investigating Histopathological and Immunohistochemical Markers for Tailored Diagnosis and Therapeutic Innovations
Por: Ana-Maria Ciongariu, et al.
Publicado em: (2024-06-01)

Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
Por: Ulmert, D, et al.
Publicado em: (2009)